Startup AI Diagnostics showcased its tuberculosis monitor at MWC 2026, which could one day scan for other lung- and heart-related diseases.
Dar es Salaam. Tanzania has officially registered Lenacapavir, a long-acting injectable drug for the prevention and control of HIV, marking what officials describe as a significant milestone in the ...
AI-enabled stethoscopes can detect heart valve disease and help screen for tuberculosis earlier. New research shows how digital stethoscopes may improve frontline diagnosis.
It's designed to take the place of complicated, multiple drug regimens that many people with HIV need to follow. And it's ...
On March 2, the 2026 Mobile World Congress kicked off in Barcelona, Spain, with UniCom and other Chinese tech companies ...
Health and Me on MSN
Reducing mother-to-child HIV transmission to zero key to end AIDS in India: Experts
As per the latest National AIDS Control Organization (NACO) report, 83 percent of all pregnant women are tested for HIV, and 78 percent of all pregnant women are tested for syphilis in India.
Introduction Incidental pulmonary nodules (IPNs) are commonly encountered on chest radiographs (CXRs) performed for routine clinical indications and may represent early manifestations of significant ...
Commerce Public Schools provided an update on Wednesday regarding a tuberculosis case within the district. According to Commerce Public Schools, the individual is part of Alexander Elementary, and ...
Researchers at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo have developed a new inhalable form of tuberculosis (TB) treatment that could significantly ...
Despite major advances in diagnostics and treatment, tuberculosis (TB) remains the world's deadliest infectious disease. In a ...
An iron-based compound encapsulated in lipid nanoparticles completely eliminated tuberculosis in the lungs of mice after 30 days of treatment, according to a study by the Tuberculosis Research ...
A six-month all-oral regimen for MDR/RR-TB is more effective and cost-saving in India The BPaL regimen costs INR 379 less per patient per additional QALY gained than standard care Shorter six-month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results